Understanding the Cervical Cancer Crisis
Insights from Professor Lola Adeyemi
Professor Lola Adeyemi, MBBS, MPH, MLA, is a physician, entrepreneur, and advocate for health equity with expertise in public and preventive health, clinical trials, and the pharmaceutical industry. As the co-founder and Chief Operations Officer of Magna Carta Health, she is transforming preventative healthcare in Nigeria through technology-driven solutions. She also founded Clinicgoto, an app improving healthcare access, and Mentoring Her, a platform connecting female mentors and mentees. A recipient of the Forbes Next1000 Honoree Award (2021) and the Johns Hopkins Global Achievement Award (2020), Professor Adeyemi is recognized globally for her innovative approaches to reducing health disparities and advancing patient-centered care.
In this insightful interview with STO, Professor Adeyemi shares her perspectives on cervical cancer. Despite being the second most common cancer among women worldwide, cervical cancer remains one of the most preventable with proper education, vaccination, and screening. Dr. Adeyemi sheds light on the barriers to care, exciting advancements like self-testing kits, and the transformative role of technology in educating healthcare professionals.
Join us as Professor Adeyemi highlights actionable strategies to close gaps in cervical cancer care and emphasizes the importance of empowering individuals and communities to take charge of their health.
What is one lesser-known fact about cervical cancer that you wish everyone understood?
Cervical cancer is the second most common cancer among women globally, yet it is one of the most preventable cancers, thanks to effective vaccination and screening methods. It appears that people are either not aware, do not understand, or do not care.
What do you believe is the most significant gap in cervical cancer care today, and how can it best be addressed?
The most significant gap is inadequate screening, largely due to a lack of awareness, education, and access. Addressing this gap requires comprehensive education on the importance of screening, prevention, and management, alongside expanding access to screening through innovative approaches like self-screening.
How can organizations like STO best support the ongoing education of healthcare professionals in the field of cervical cancer screening, prevention, and treatment?
Technology can play a pivotal role in advancing education. With smartphones being ubiquitous, leveraging mobile platforms to provide easily accessible, digestible, and up-to-date information on cervical cancer management will significantly enhance the knowledge and skills of healthcare professionals.
What recent advancements in cervical cancer research are you most excited about, and why?
I am particularly excited about community-based solutions, such as self-testing kits. These innovations empower individuals, particularly in underserved areas, to take control of their health, thus improving access to screening and fostering greater equity in cervical cancer care.